Results 11 to 20 of about 23,023 (232)

Role of artificial intelligence in diagnosing Barrett’s esophagus-related neoplasia [PDF]

Clinical Endoscopy, 2023
Barrett’s esophagus is associated with an increased risk of adenocarcinoma. Thorough screening during endoscopic surveillance is crucial to improve patient prognosis.
Michael Meinikheim, Helmut Messmann, Alanna Ebigbo   +2 more
doaj   +1 more source

Reduced risk of Barrett’s esophagus in statin users: case–control study and meta-analysis [PDF]

, 2016
Background: Use of statins has been associated with a reduced incidence of esophageal adenocarcinoma in population-based studies. However there are few studies examining statin use and the development of Barrett’s esophagus.
A Dubecz, A Goldberg, AP Thrift, BC Jacobson, D Fang, D Lin, DM Nguyen, E Cheong, E Long, F Kastelein, F Yousef, G Balasubramanian, GM Masclee, I Beales, Ian L. P. Beales, IL Beales, IL Beales, IL Beales, IL Beales, IL Beales, Inna Vardi, JH Rubenstein, K Yokota, L Alexandre, L Alexandre, L Alexandre, Leanne Dearman, LM Brown, M Dovizio, M Sikkema, N Sivarasan, NJ Shaheen, O Ogunwobi, OO Ogunwobi, OO Ogunwobi, OO Ogunwobi, PE Lazzerini, S Singh, S Zhang, T Broughton, T Broughton, T Nguyen, TK Desai, TV Macfarlane, X Wu, Y Fang, Yoon Loke, ZB Omer   +47 more
core   +1 more source

Recurrence of intestinal metaplasia and early neoplasia after endoscopic eradication therapy for Barrett’s esophagus: A systematic review and meta-analysis [PDF]

, 2017
Background Conflicting data exist with regard to recurrence rates of intestinal metaplasia (IM) and dysplasia after achieving complete eradication of intestinal metaplasia (CE-IM) in Barrett’s esophagus (BE) patients.
Cinnor, Birtukan, Das, Ananya, Early, Dayna S, Edmundowicz, Steven A, Fujii-Lau, Larissa L, Gaddam, Srinivas, Komanduri, Srinadh, Kushnir, Vladimir, Mullady, Daniel, Muthusamy, V. Raman, Shaheen, Nicholas, Simon, Violette C, Wani, Sachin, Wilson, Robert   +13 more
core   +2 more sources

Germline variant in MSX1 identified in a Dutch family with clustering of Barrett’s esophagus and esophageal adenocarcinoma [PDF]

, 2017
The vast majority of esophageal adenocarcinoma cases are sporadic and caused by somatic mutations. However, over the last decades several families have been identified with clustering of Barrett’s esophagus and esophageal adenocarcinoma. This observation
Biermann, K. (Katharina), Dinjens, W.N.M. (Winand), IJcken, W.F.J. (Wilfred) van, Klein, A. (Annelies) de, Lanschot, J.J.B. (Jan) van, Marion, R. (Ronald) van, Nistelrooij, A.M.J. (Annemarie) van, Spaander, M.C.W. (Manon), Wagner, A. (Anja), Wijnhoven, B.P.L. (Bas)   +9 more
core   +1 more source

Is It Barrett's Esophagus or Gastric Heterotopia

Case Reports in Gastroenterology, 2014
Columnar epithelium in the distal part of the esophagus is generally related to Barrett's esophagus. Barrett's esophagus is a well-known premalignant lesion for adenocarcinoma of the esophagus.
Zeynel Mungan
doaj   +1 more source

Sex steroid hormones in relation to Barrett’s esophagus: An analysis of the FINBAR Study [PDF]

, 2017
Previously we observed strong positive associations between circulating concentrations of free testosterone and free dihydrotestosterone (DHT) in relation to Barrett’s esophagus in a US male military population.
Abnet, Christian C, Anderson, Lesley A, carson, Patrick, Cook, M. B., Dawsey, Sanford M, Drahos, Jennifer, Falk, Roni T, Guillemette, Chantal, Hyland, Paula L, Murray, Liam J, Pfeiffer, Ruth, Taylor, Philip R, Wood, Sharon   +12 more
core   +1 more source

Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro

Molecular Cancer, 2006
Background Barrett's esophagus, a risk factor for esophageal adenocarcinoma, is associated with reflux disease. The aim of this study was to assess the expression of bile acid receptors in the esophagus (normal, esophagitis, Barrett's esophagus and ...
Frossard Jean-Louis, Rubbia-Brandt Laura, Spahr Laurent, Morard Isabelle, Vonlaufen Alain, Bruttin Fabien, Dumonceau Jean-Marc, De Gottardi Andrea, Dinjens Winand NM, Rabinovitch Peter S, Hadengue Antoine   +10 more
doaj   +1 more source

Modeling inflammation and oxidative stress in gastrointestinal disease development using novel organotypic culture systems. [PDF]

, 2013
Gastroesophageal reflux disease (GERD), Barrett's esophagus (BE), graft-versus-host disease (GVHD), and inflammatory bowel diseases such as ulcerative colitis and Crohn's disease are common human gastrointestinal diseases that share inflammation as a key
Bortner, James D, Falk, Gary W, Hartman, Kira G, Lynch, John P, Martín, Martín G, Rustgi, Anil K, Yu, Jian   +6 more
core   +2 more sources

Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis. [PDF]

, 2014
Barretts esophagus (BE) involves a metaplastic replacement of native esophageal squamous epithelium (Sq) by columnar-intestinalized mucosa, and it is the main risk factor for Barrett-related adenocarcinoma (BAc).
Baffa, R, Bornschein, J, Braconi, C, Croce, CM, D'Angelo, E, Dall'Olmo, L, Fassan, M, Galasso, M, Gasparini, P, Nuovo, GJ, Pizzi, M, Realdon, S, Rugge, M, Souza, RF, Valeri, N, Vicentini, C, Volinia, S, Zaninotto, G   +17 more
core   +4 more sources

Barrett’s Esophagus in Patients with Gastroesophageal Reflux Disease

Journal of Nepal Health Research Council, 2018
Background: Barrett’s esophagus a is metaplasia of normal squamous cells that line the lower part of the esophagus and carries a major risk for adenocarcinoma of esophagus.
Khus Raj Dewan, Bhanumati Saikia Patowary, Subash Bhattarai, Gaurav Shrestha   +3 more
doaj   +1 more source